483 Document: Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical, Aug 20, 2021

Dustin M. James, FDA Investigator
Alan P. Kurtzberg, FDA Investigator

FDANews 483 Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical Aug 20 2021 top

Dustin M. James FDA Investigator Alan P. Kurtzberg FDA Investigator

On Aug 20, 2021, the FDA inspected Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical's Salt Lake City site. Explore the inspectional observations.